Cite
Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.
MLA
Mohamed Suffian, Izzat Fahimuddin Bin, et al. “Engineering Hepatitis B Virus Core Particles for Targeting HER2 Receptors in Vitro and in Vivo.” Biomaterials, vol. 120, Mar. 2017, pp. 126–38. EBSCOhost, https://doi.org/10.1016/j.biomaterials.2016.12.012.
APA
Mohamed Suffian, I. F. B., Wang, J. T.-W., Hodgins, N. O., Klippstein, R., Garcia-Maya, M., Brown, P., Nishimura, Y., Heidari, H., Bals, S., Sosabowski, J. K., Ogino, C., Kondo, A., & Al-Jamal, K. T. (2017). Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo. Biomaterials, 120, 126–138. https://doi.org/10.1016/j.biomaterials.2016.12.012
Chicago
Mohamed Suffian, Izzat Fahimuddin Bin, Julie Tzu-Wen Wang, Naomi O. Hodgins, Rebecca Klippstein, Mitla Garcia-Maya, Paul Brown, Yuya Nishimura, et al. 2017. “Engineering Hepatitis B Virus Core Particles for Targeting HER2 Receptors in Vitro and in Vivo.” Biomaterials 120 (March): 126–38. doi:10.1016/j.biomaterials.2016.12.012.